These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ. Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214 [Abstract] [Full Text] [Related]
13. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Jennings DL, Taber DJ. Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340 [Abstract] [Full Text] [Related]
15. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation. Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L. Clin Transplant; 2008 Jan; 22(4):439-46. PubMed ID: 18318741 [Abstract] [Full Text] [Related]
16. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors. Seeman T, Pohl M, Misselwitz J, John U. Kidney Blood Press Res; 2009 Jan; 32(6):440-4. PubMed ID: 20016211 [Abstract] [Full Text] [Related]
19. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration. Esnault VL, Ekhlas A, Nguyen JM, Moranne O. Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824 [Abstract] [Full Text] [Related]
20. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients. Han SW, Won YW, Yi JH, Kim HJ. Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]